Clinical use of the somatostatin analog SMS 201-995 in endocrinology
- PMID: 2852695
- DOI: 10.1007/BF03350937
Clinical use of the somatostatin analog SMS 201-995 in endocrinology
Similar articles
-
Octreotide: a somatostatin analog.Am Fam Physician. 1989 Jun;39(6):207-11. Am Fam Physician. 1989. PMID: 2543196 Review. No abstract available.
-
NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut.Ann Intern Med. 1989 Jan 1;110(1):35-50. doi: 10.7326/0003-4819-110-1-35. Ann Intern Med. 1989. PMID: 2535688 Review.
-
Non-pituitary actions of somatostatin. A review on the therapeutic role of SMS 201-995 (sandostatin).Acta Endocrinol Suppl (Copenh). 1986;276:41-55. doi: 10.1530/acta.0.111s0041. Acta Endocrinol Suppl (Copenh). 1986. PMID: 2875590 Clinical Trial.
-
[Therapeutic use of somatostatin analogues in endocrinology].Recenti Prog Med. 1992 Nov;83(11):626-33. Recenti Prog Med. 1992. PMID: 1363150 Review. Italian.
-
Endocrine applications of the somatostatin analogue octreotide (Sandostatin).Metabolism. 1992 Sep;41(9 Suppl 2):34-8. doi: 10.1016/0026-0495(92)90028-9. Metabolism. 1992. PMID: 1518431 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical